JSLL Jeena Sikho Q1 FY27 results (Apr–Jun 2026) and concall
Jeena Sikho reported strong Q1 FY27 results with 29% YoY revenue growth and robust margins, driven by its integrated healthspan philosophy and growth in both product and service segments. The company is strategically reducing government business, expanding into ultra-luxury wellness, and preparing for Ayushman Yojana. Investments in technology and operational efficiency are underway to support ambitious long-term targets of ₹3,000 crores turnover and ₹1,000 crores PAT.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q1 FY27: revenue up 28.7%, net profit up 29.4% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 114 | 116 | 139 | 174 | 190 +67% | 222 +91% | 216 +55% | 224 +29% |
| EBITDA | 40 | 30 | 46 | 79 | 92 +130% | 101 +237% | 78 +70% | 92 +16% |
| Net profit | 27 | 13 | 25 | 51 | 59 +119% | 67 +415% | 45 +80% | 66 +29% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
